Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010841 · ClinicalTrials.gov registry record · NA
Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome
A NA study, sponsored by MetaProteomics.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT01010841: Completed NA study, sponsored by MetaProteomics.
NCT01010841 is a NA study that has completed, run by MetaProteomics. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01010841, a NA study, has completed, sponsored by MetaProteomics.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The objective of this study was to investigate from 3 sites (University of Connecticut, University of Florida, and University of California, Irvine) whether enhancement of a modified Mediterranean-style, low glycemic load diet (MED) with specific phytochemicals (soy protein, phytosterols, rho iso-alpha acids and proanthocyanidins; PED) could improve cardiometabolic risk factors in women with metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT UltraMealPlus 360 (Medical food)
- OTHER Low-glycemic-load diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010841
The ClinicalTrials.gov registry entry for NCT01010841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetaProteomics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which UltraMealPlus 360 (Medical food) is the first listed.
NCT01010841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010841 about?
NCT01010841 is a clinical study titled "Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome". The objective of this study was to investigate from 3 sites (University of Connecticut, University of Florida, and University of California, Irvine) whether enhancement of a modified Mediterranean-style, low glycemic load diet (MED) with specific phytochemicals (soy protein, phytosterols, rho iso-al...
What is the current status of trial NCT01010841?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2008-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01010841?
The interventions under investigation include: UltraMealPlus 360 (Medical food) (DIETARY_SUPPLEMENT), Low-glycemic-load diet (OTHER).
Who is sponsoring clinical trial NCT01010841?
This trial is sponsored by MetaProteomics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.